Francesca Borgna

Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms

Francesca Borgna, Stephanie Haller, Josep M. Monné Rodríguez et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 106 citations · Full text

Medicine, Oncology, Pharmacology +17

Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity

Luisa M. Deberle, Martina Benešová, Christoph A. Umbricht et al. · Theranostics · 2020 · 97 citations · Full text

Medicine, Pharmaceutics, Pharmacology +17

The RIB production target for the SPES project

A. Monetti, A. Andrighetto, Carlo Petrovich et al. · The European Physical Journal A · 2015 · 50 citations · Full text

Engineering, Biosystems Engineering, Production Systems +2

Therapeutic Potential of 47Sc in Comparison to 177Lu and 90Y: Preclinical Investigations

Klaudia Siwowska, Patrycja Guzik, Katharina A. Domnanich et al. · Pharmaceutics · 2019 · 47 citations · Full text

Medicine, Oncology, Pharmacology +15

Cyclotron production and radiochemical purification of terbium-155 for SPECT imaging

Chiara Favaretto, Zeynep Talip, Francesca Borgna et al. · EJNMMI Radiopharmacy and Chemistry · 2021 · 46 citations · Full text

Medicine, Nuclear Medicine, Radiology +15